Abstract:In order to obtain a simple,fast,accurate and low-cost diagnosis method of fragile X syndrome, cytogenetic tests and molecular genetic tests were carried out with direct amplification of (CGG)(n) repeat sequence in 5' terminal of FMR1 gene by PCR and the cDNA sequence of FMR1 by RT-PCR from six mental retardation pedigrees. The proband of pedigree A with high expression of fragile X chromosome(35/273) was detected to be a full mutation patient of fragile X syndrome by the molecular genetic test. There is no expression of fragile X chromosome in the proband and his mother of pedigree B, which was further confirmed as a non-fragile X pedigree by the molecular genetic test. A male foetus of the pedigree C has fragile X chromosome(5/93), but the proband and his mother has no fragile X chromosome. By further detection using molecular genetic test, the male foetus is a full mutation patient of fragile X syndrome, his mother is a permutated carrier, and his brother is a mosaic patient. The proband of pedigree D has high expression of fragile X chromosome (17%), his sister also has expression of fragile X chromosome (5%). By further detection with molecular genetic test, the proband is a full mutation patient of fragile X syndrome,and his sister is a mosaic patient. The probands of pedigrees E and F of the mother were found with suspicions fragile X chromosome, being confirmed as the non-fragile X pedigrees by the molecular genetic test. The conclusion is that the analysis test with direct amplification of 5'j(CGG)n repeat sequence and cDNA sequence in FMR1 gene is simple,fast,low-cost and can be applied in screening, diagnosis and prenatal diagnosis of fragile X syndrome.

Progress in Diagnostic Methods for Fragile X Syndrome

Genetic Diagnosis and Prenatal Genetic Diagnosis of Fragile X Syndrome

Epigenetic insights into Fragile X Syndrome

Expressions of Drebrins and Lcam-5 in Mouse Cerebral Cortex with Fmr-1 Gene Knockout and Their Significance in Fragile X Syndrome

Potential Pharmacological Treatment of Fragile X Syndrome During Adulthood

Development of Chinese Genetic Reference Panel for Fragile X Syndrome and Its Application to the Screen of 10,000 Chinese Pregnant Women and Women Planning Pregnancy

New Targeted Treatments for Fragile X Syndrome

Prenatal diagnosis and genetic counseling of fragile X syndrome in four pedigrees by using high-resolution multiplex polymerase chain reaction

Application of triplet repeat-primed-PCR and methylation specific multiplex ligation-dependent probe amplification in prenatal diagnosis of fragile X syndrome

Fragile X Syndrome: Prevalence, Treatment, and Prevention in China

Fragile X Syndrome: From Molecular Aspect to Clinical Treatment

Proteomics insights into fragile X syndrome: Unraveling molecular mechanisms and therapeutic avenues

Screening and genetic diagnosis of fragile X syndrome among mentally retarded children

Comprehensive Analysis of Fragile X Syndrome: Full Characterization of the FMR1 Locus by Long-Read Sequencing

Evaluation of peripheral blood lymphocyte FMRP detection for diagnosing fragile X syndrome in children

Fragile X Syndrome: A Review for General Pediatricians

Clinical manifestation and molecular mechanism of FMR1 gene premutation

Fragile X syndrome screening in Chinese children with unknown intellectual developmental disorder

Analysis on Knowledge, Attitude, Behavior about Fragile X Syndrome among Parents with Mentally Retarded Students

Molecular Pathogenesis and Peripheral Monitoring of Adult Fragile X-Associated Syndromes

Fragile X Syndrome Carrier Screening Using a Nanopore Sequencing Assay